pediatric off-label use ethics
Reveal Experts’ Secrets On Glp-1 / Weight‑Loss Drugs Ethics
In 2024, 62 deaths were reported in Australia linked to GLP-1 drugs, underscoring the need for rigorous safeguards when considering off-label use in children. Off-label use of GLP-1 drugs in children is ethically permissible only when strict safety protocols, informed consent, and oversight are in place. Medical Disclaimer: This article